Molecular Advances in Diagnosis and Treatment of CNS Tumors

181.2K

views

184

authors

24

articles

Editorial

25 September 2020

Editorial: Molecular Advances in Diagnosis and Treatment of CNS Tumors

Zhao-Hui Zhang

,

Ming-Tseh Lin

and

Liam Chen

3,089 views

1 citations

Editors

3

Liam Chen

Medical School, University of Minnesota

Ming-Tseh Lin

Johns Hopkins University

Zhaohui Zhang

Renmin Hospital of Wuhan University

Impact

Fetching...

About

Due to rapid development of next generation sequencing techniques, molecular-genetic analysis has now become an integral part of the modern surgical neuropathology. Modern diagnosis of CNS tumors typically combines the results from histologic and immunohistochemical examinations of microscopic slides with the key DNA/RNA genetic changes identified in the molecular pathology testing. This has led to a substantial reclassification of various brain and spinal cord tumors, including the introduction of new neoplastic entities and removal of others.

Involvement of key tumor suppressor genes and oncogenes in brain tumor development has been known for decades, but recent studies have highlighted many unexpected and novel mutations occurring in adult and pediatric brain tumors. These emerging discoveries further emphasize the importance of identifying state-of-the-art molecular signatures for diagnosing CNS malignancy and development of novel targeted therapies. In particular, understanding the molecular landscapes of pediatric high-grade astrocytic tumors and embryonal tumors, capitalizing immunotherapy, which may have the power to revolutionize brain tumor treatment, are just a few of the many challenges that this field is currently facing.

In this Research Topic, we intend to collate key research findings in the field of molecular diagnosis of CNS tumors and invite contributions in form of Original Research articles, Reviews, Case Reports and Clinical Trials relating to any of the following:

1) Molecular characterization of CNS tumors and their transit from origin to progression,
2) Identification of biomarkers for detection of CNS tumors at early stages and their response to treatment,
3) Identification of novel drug targets and therapies for the treatment of CNS tumors.

Download ebook

PDF

EPUB

Share

Editors

Liam Chen

Medical School, University of Minnesota

Ming-Tseh Lin

Johns Hopkins University

Zhaohui Zhang

Renmin Hospital of Wuhan University

Impact

181,204 Total views

140,635 Article views

38,734 Article downloads

1,835 Topic views

Published In

Frontiers in Oncology

Neuro-Oncology and Neurosurgical Oncology

Frontiers in Neurology

Neuro-Oncology and Neurosurgical Oncology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic